JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Late-onset Stevens–Johnson syndrome due to nivolumab use for hepatocellular carcinoma

A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies

Tacrolimus for the treatment of immune-related adverse effects refractory to systemic steroids and anti-tumor necrosis factor α therapy

Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management

Introduction of a dose-banding system for parenteral chemotherapy on a haematology–oncology day ward

Drug cost avoidance in clinical trials of breast cancer

Integration of clinical pharmacists into an ambulatory, pediatric hematology/oncology/transplant clinic

A novel drug interaction between busulfan and blinatumomab

Isavuconazole therapy in an FLT3 mutated acute myeloid leukemia patient receiving midostaurin: A case report

Using a treatment diary to improve the medication adherence in patients with chronic myeloid leukaemia

Implementation of a student pharmacist-driven medication history service for ambulatory oncology patients in a large academic medical center

Financial impact of oral chemotherapy wastage on society and the patient

Cilioretinal artery occlusion associated with cisplatin

Severe arthritic syndrome due to ibrutinib use for chronic lymphocytic leukemia

Pharmacist-led patient education and adverse event management in patients with non-small cell lung cancer receiving afatinib in a community-based, real-world clinical setting

Durable response after interruption of nivolumab in patients with metastatic renal cell carcinoma: Is renal toxicity a marker to predict the benefit of nivolumab?

Toxic epidermal necrolysis associated with pembrolizumab

Propofol-based balanced anesthesia is safer in pediatric radiotherapy

Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity

Impact of the introduction of novel hormonal agents on metastatic castration-resistant prostate cancer treatment choice

Nivolumab-induced type 1 diabetes mellitus as an immune-related adverse event

Severe first infusion reaction related to cetuximab in cancer patients in Arkansas

Development of a flowchart for risk assessment and allocation of preparation of monoclonal antibodies

Elevated beta human chorionic gonadotropin in a non-pregnant female diagnosed with anal squamous cell carcinoma

Passive-specific immunotherapy with monoclonal antibodies for prostate cancer: A systematic review

An advanced c-MET-amplified NSCLC patient that was treated with crizotinib

The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma

Approach to initiating QT-prolonging oncology drugs in the ambulatory setting

Perceptions and expectations of health care providers towards clinical pharmacy services at a tertiary cancer centre in Qatar

Bevacizumab-induced dysphonia: A case report with brief review of literature

Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma

Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma

Appropriateness of using granulocyte colony-stimulating factor (G-CSF) for primary prophylaxis of febrile neutropenia in solid tumors

Clinico-epidemiologic characteristics and patterns of care in Kaposi’s sarcoma: Data from a single-institution series

Cyclophosphamide desensitization in patients with severe hypersensitivity reactions to bendamustine

Development of pneumonitis after rituximab treatment in a patient with lymphoma

Factors associated with longer endocrine therapy use by South Carolina Medicaid-insured breast cancer survivors

Field evaluation of onsite near real-time monitors for surface contamination by 5-fluorouracil

Radiation oncology outpatient medication management needs and service gaps – A cross-sectional study of patients and clinicians

Obesity is not strongly associated with increased risk for febrile neutropenia during levofloxacin prophylaxis in patients with hematological malignancies receiving intermediate-risk myelosuppressive chemotherapy

Drug shortages in a pediatric stem cell transplantation ward: Challenges and implications. A 5-year bilan

Use of leftovers of monoclonal antibody products after partial extraction – A microbiological safety study

Drug-related problems with targeted/immunotherapies at an oncology outpatient clinic

Treatment exceeds expectations in a patient with non-small cell lung adenocarcinoma with an EGFR exon 20 mutation

The role of antimicrobial prophylaxis in patients with head and neck cancer undergoing chemoradiation

Comments on “Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study”

Evaluation of appropriate use of bisphosphonates and denosumab in patients with cancer